Assignee
PROBIODRUG AG
DE·38 granted patents·19 pending applications·829 citations·filing 2000–2020
Top patents by PatentIndex Score
57 records- 0197US7732162B2Inhibitors of glutaminyl cyclase for treating neurodegenerative diseasesPROBIODRUG AG·Filed 2007·Granted Jun 8, 2010·51 cites·19 claims
- 0297US6548481B1Effectors of dipeptidyl peptidase IVPROBIODRUG AG·Filed 2000·Granted Apr 15, 2003·249 cites·14 claims
- 0396US7371871B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2004·Granted May 13, 2008·90 cites·20 claims
- 0496US7304086B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2005·Granted Dec 4, 2007·64 cites·38 claims
- 0596US6500804B2Method for the improvement of islet signaling in diabetes mellitus and for its preventionPROBIODRUG AG·Filed 2001·Granted Dec 31, 2002·97 cites·11 claims
- 0694US7381537B2Use of inhibitors of glutaminyl cyclases for treatment and prevention of diseasePROBIODRUG AG·Filed 2004·Granted Jun 3, 2008·62 cites·27 claims
- 0794US7109347B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2005·Granted Sep 19, 2006·19 cites·5 claims
- 0894US6844316B2Inhibitors of dipeptidyl peptidase IPROBIODRUG AG·Filed 2002·Granted Jan 18, 2005·38 cites·16 claims
- 0991US7368576B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2006·Granted May 6, 2008·9 cites·10 claims
- 1089US7462599B2Use of effectors of glutaminyl and glutamate cyclasesPROBIODRUG AG·Filed 2004·Granted Dec 9, 2008·31 cites·14 claims
- 1189US7435420B2Dipeptidyl peptidase IV inhibitors for the treatment of anxietyPROBIODRUG AG·Filed 2006·Granted Oct 14, 2008·8 cites·16 claims
- 1286US6949515B2Effectors of dipeptidyl peptidase IV for topical usePROBIODRUG AG·Filed 2002·Granted Sep 27, 2005·22 cites·19 claims
- 1385US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 1485US9650362B2InhibitorsPROBIODRUG AG·Filed 2015·Granted May 16, 2017·5 cites·17 claims
- 1585US7741354B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Jun 22, 2010·11 cites·23 claims
- 1685US7625939B2Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase IV inhibitorsPROBIODRUG AG·Filed 2008·Granted Dec 1, 2009·10 cites·18 claims
- 1785US7084120B2Prodrugs of DP IV-inhibitorsPROBIODRUG AG·Filed 2000·Granted Aug 1, 2006·25 cites·7 claims
- 1881US7592467B2Inhibitors of prolyl endopeptidasePROBIODRUG AG·Filed 2006·Granted Sep 22, 2009·7 cites·44 claims
- 1981US7132104B1Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disordersPROBIODRUG AG·Filed 2001·Granted Nov 7, 2006·12 cites·3 claims
- 2077US7655684B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2008·Granted Feb 2, 2010·2 cites·18 claims
- 2176US7368421B2Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosisPROBIODRUG AG·Filed 2002·Granted May 6, 2008·4 cites·13 claims
- 2274US9173885B2InhibitorsPROBIODRUG AG·Filed 2013·Granted Nov 3, 2015·2 cites·32 claims
- 2374US7667044B2Compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2005·Granted Feb 23, 2010·2 cites·45 claims
- 2472US7144856B2Inhibitors of dipeptidyl peptidase IPROBIODRUG AG·Filed 2004·Granted Dec 5, 2006·1 cites·20 claims
- 2572US6559314B2Method for the production of thiazolidinPROBIODRUG AG·Filed 2001·Granted May 6, 2003·5 cites·12 claims
- 2670US7803810B2InhibitorsPROBIODRUG AG·Filed 2008·Granted Sep 28, 2010·1 cites·19 claims
- 2769US2010028918A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 2867US11045533B2Humanized antibodiesPROBIODRUG AG·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 2966US9610368B2Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of samePROBIODRUG AG·Filed 2014·Granted Apr 4, 2017·0 cites·17 claims
- 3060US2010159032A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 3159US2008249083A1Novel genes related to glutaminyl cyclasePROBIODRUG AG·Filed 2007·Application pending·0 cites
- 3257US9157918B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)PROBIODRUG AG·Filed 2013·Granted Oct 13, 2015·0 cites·7 claims
- 3357US7897633B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Mar 1, 2011·0 cites·23 claims
- 3457US2017097365A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2016·Application pending·0 cites
- 3554US9657089B2Diagnostic antibody assayPROBIODRUG AG·Filed 2014·Granted May 23, 2017·0 cites·20 claims
- 3654US8859250B2Crystal structure of glutaminyl cyclasePROBIODRUG AG·Filed 2013·Granted Oct 14, 2014·0 cites·13 claims
- 3754US7728146B2Enzyme inhibitorsPROBIODRUG AG·Filed 2007·Granted Jun 1, 2010·0 cites·65 claims
- 3853US2015247180A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 3953US2005171112A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 4051US7335645B2Effectors of dipeptidyl peptidase IV for topical usePROBIODRUG AG·Filed 2005·Granted Feb 26, 2008·0 cites·16 claims
- 4151US2010099721A1Novel compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 4248US9676843B2Uses of antibodies directed against amyloid-βPROBIODRUG AG·Filed 2015·Granted Jun 13, 2017·0 cites·26 claims
- 4348US2010273835A1Novel compoundsPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 4446US2015361167A1Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)PROBIODRUG AG·Filed 2015·Application pending·0 cites
- 4546US2005137142A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 4645US9512115B2InhibitorsPROBIODRUG AG·Filed 2014·Granted Dec 6, 2016·0 cites·22 claims
- 4745US2008200567A1In vivo screening models for treatment of alzheimer's disease and other qpct-related disordersPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 4843US9277737B2Mouse models carrying a knock-out mutation of the QPCTL-genePROBIODRUG AG·Filed 2013·Granted Mar 8, 2016·0 cites·19 claims
- 4942US2010234397A1Enzyme inhibitorsPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 5041US7279550B2Irreversible cysteine protease inhibitors of legumainPROBIODRUG AG·Filed 2002·Granted Oct 9, 2007·0 cites·7 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →